EGenesis

United States
Primghar, Iowa, United States, 02143

Company profile

EGenesis company profile

EGenesis is a biotechnology company developing solid organ and therapeutic cell transplantation to treat diseases. It offers gene editing and genome engineering platform to develop human-compatible organs, tissues, and cells, aiming to provide an alternative solution to the global organ shortage.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$1M-$10M
Founded
2014-01-01, Year

Headquarters

Postal code
02143
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
5
Total equity funding
$454M
Last funding
Series D / $191M / 2024-09-04
Last equity funding
Series D / $191M
Investors
31
Lead investors
4
Founders
3
Articles
91

Founders and investors

Founders

Geoff MacKayGeorge ChurchLuhan Yang

Lead investors

ARCH Venture PartnersBiomatics Capital PartnersFresenius Medical CareLux Capital

Investors

ARCH Venture PartnersCatalio Capital ManagementKhosla VenturesLux CapitalPolaris Partners